Analyst ratings, especially from reputable firms like Needham, can influence investor sentiment and stock prices. However, a Hold rating typically suggests that the analyst sees the stock as fairly valued at its current price, implying no significant short-term price movement is expected. Therefore, the impact on Moderna's stock price in the short term is likely to be minimal, as the market has likely already priced in the factors leading to the Hold rating.